Shanhe Wan is a lab master, School of Pharmaceutical Science, Southern Medical University.
The author's education background: 2012–2015, Southern Medical University, pharmacology, Master; 2005–2008, Guangdong Pharmaceutical University, pharmacy, Bachelor.
The author's work experience: 2018–2023, Southern Medical University, Experimental Center of School of Pharmaceutical Science, lab master; 2015–2018, Southern Medical University, Experimental Center of School of Pharmaceutical Science, laboratory technician; 2004–2012, Southern Medical University, Experimental Center of School of Pharmaceutical Science, technician; 1995–2004, First Military Medical University, Institute of Pharmacology, technician.
The author's current and previous research interests include design and the mechanism and structure–activity relationship of EGFR inhibitors.
Representative works:
(1) Wan Shanhe, Yan Ruohong, Jiang Ying, Li Zhonghuang, Zhang Jiajie*, Wu Xiaoyun*. Insight into binding mechanisms of EGFR allosteric inhibitors using molecular dynamics simulations and free energy calculations. J Biomol Struct Dyn, 2019: 37(16):4384-94.
(2) Ju Hou#;Shanhe Wan#; Guangfa Wang; Tingting Zhang; Zhonghuang Li; Yuanxin Tian; Yonghuan Yu; Xiaoyun Wu*; Jiajie Zhang*; Design, synthesis, anti-tumor activity, and molecular modeling of quinazoline and pyrido[2,3-d]pyrimidine derivatives targeting epidermal growth factor receptor. Eur J Med Chem, 2016, 118: 267-289.
Shanhe Wan is a lab master, School of Pharmaceutical Science, Southern Medical University.
The author's education background: 2012–2015, Southern Medical University, pharmacology, Master; 2005–2008, Guangdong Pharmaceutical University, pharmacy, Bachelor.
The author's work experience: 2018–2023, Southern Medical University, Experimental Center of School of Pharmaceutical Science, lab master; 2015–2018, Southern Medical University, Experimental Center of School of Pharmaceutical Science, laboratory technician; 2004–2012, Southern Medical University, Experimental Center of School of Pharmaceutical Science, technician; 1995–2004, First Military Medical University, Institute of Pharmacology, technician.
The author's current and previous research interests include design and the mechanism and structure–activity relationship of EGFR inhibitors.
Representative works:
(1) Wan Shanhe, Yan Ruohong, Jiang Ying, Li Zhonghuang, Zhang Jiajie*, Wu Xiaoyun*. Insight into binding mechanisms of EGFR allosteric inhibitors using molecular dynamics simulations and free energy calculations. J Biomol Struct Dyn, 2019: 37(16):4384-94.
(2) Ju Hou#;Shanhe Wan#; Guangfa Wang; Tingting Zhang; Zhonghuang Li; Yuanxin Tian; Yonghuan Yu; Xiaoyun Wu*; Jiajie Zhang*; Design, synthesis, anti-tumor activity, and molecular modeling of quinazoline and pyrido[2,3-d]pyrimidine derivatives targeting epidermal growth factor receptor. Eur J Med Chem, 2016, 118: 267-289.